Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

International Stem Cell (ISCO) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $29000.0.

  • International Stem Cell's Net Income towards Common Stockholders rose 12320.0% to $29000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$148000.0, marking a year-over-year increase of 7986.39%. This contributed to the annual value of -$213000.0 for FY2024, which is 7344.14% up from last year.
  • Latest data reveals that International Stem Cell reported Net Income towards Common Stockholders of $29000.0 as of Q3 2025, which was up 12320.0% from $67000.0 recorded in Q2 2025.
  • International Stem Cell's Net Income towards Common Stockholders' 5-year high stood at $259000.0 during Q2 2023, with a 5-year trough of -$641000.0 in Q3 2021.
  • Over the past 5 years, International Stem Cell's median Net Income towards Common Stockholders value was -$125000.0 (recorded in 2024), while the average stood at -$166526.3.
  • The largest annual percentage gain for International Stem Cell's Net Income towards Common Stockholders in the last 5 years was 1305000.0% (2023), contrasted with its biggest fall of 173571.43% (2023).
  • Over the past 5 years, International Stem Cell's Net Income towards Common Stockholders (Quarter) stood at -$364000.0 in 2021, then surged by 107.69% to $28000.0 in 2022, then crashed by 1735.71% to -$458000.0 in 2023, then soared by 102.62% to $12000.0 in 2024, then soared by 141.67% to $29000.0 in 2025.
  • Its Net Income towards Common Stockholders stands at $29000.0 for Q3 2025, versus $67000.0 for Q2 2025 and -$256000.0 for Q1 2025.